Larry Henry
Optometrist · Edmond, OKNPI 1932102894
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.4% of the total across 327 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 327 payments — averaging $30.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- NEW World Medical,inc.$2K
- Alcon$1K
- AbbVie$738
- Novartis$598
- Glaukos Corporation$543
- Bausch & Lomb Americas Inc.$466
- plus $4K from 22 others
What the payments were for
- Consulting fees$6507%
- Speaking & faculty fees$260%
- Food & beverage$9,17892%
- Education$761%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| NEW World Medical,inc. | 15 | $1,795 |
| Alcon | 60 | $1,349 |
| AbbVie(2 entities) | 51 | $738 |
| Novartis | 25 | $598 |
| Glaukos Corporation | 8 | $543 |
| Bausch & Lomb Americas Inc. | 24 | $466 |
| Tarsus Pharmaceuticals, Inc. | 16 | $460 |
| Harrow Eye, LLC | 13 | $453 |
| Dompe US, Inc. | 9 | $400 |
| The Cameron-ehlen Group, Inc. | 6 | $380 |
| Aerie Pharmaceuticals, Inc. | 18 | $346 |
| Ocular Therapeutix, Inc. | 10 | $290 |
| Rxsight Inc | 8 | $269 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 12 | $235 |
| ANI Pharmaceuticals, Inc. | 6 | $194 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $168 |
| Oyster Point Pharma, Inc. | 6 | $156 |
| Eyevance Pharmaceuticals LLC | 6 | $154 |
| Sun Pharmaceutical Industries Inc. | 9 | $153 |
| Shire North American Group Inc | 2 | $139 |
| Ivantis, Inc | 1 | $137 |
| Kala Pharmaceuticals, Inc. | 2 | $130 |
| Mallinckrodt Hospital Products Inc. | 4 | $124 |
| Optos, Inc. | 1 | $108 |
| Sight Sciences, Inc. | 3 | $55 |
| Apellis Pharmaceuticals, Inc. | 3 | $54 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| Rayner Intraocular Lenses Limited | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ahmed Glaucoma Valve$1,219
- Kahook Dual Blade$1,219
- Tecnis IOL$398
- Streamline Surgical System$348
- XIIDRA$285
- KXL System$253
- Photrexa$253
- Oxervate$224
- Clearpath$221
- Streamline$221
- PANORAMIC OPHTHALMOSCOPE$216
- Hydrus$137
- HEALON PRO$133
- Tecnis Simplicity$133
- iStent inject W$128
- iStent$125
- XDEMVY$124
- PanOptix$122
- EYSUVIS$118
- Rocklatan$117
How this compares
$9,929 in reported general payments places this provider in the 95th percentile of 714 optometrist providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxervateCenegermin-Bkbj | 24 | $793,727 |
| RestasisCyclosporine | 30 | $32,407 |
| XiidraLifitegrast | 14 | $10,996 |
| VyzultaLatanoprostene Bunod | 23 | $8,553 |
| Ketorolac Tromethamine | 292 | $5,867 |
| Prednisolone Acetate | 180 | $5,177 |
| Alphagan PBrimonidine Tartrate | 14 | $4,550 |
| ValacyclovirValacyclovir Hcl | 44 | $2,064 |
| Ciprofloxacin Hcl | 123 | $1,559 |
| Latanoprost | 70 | $674 |
| MoxifloxacinMoxifloxacin Hcl | 33 | $645 |
| Timolol Maleate | 47 | $321 |
| ErythromycinErythromycin Base | 22 | $250 |
| Brimonidine Tartrate | 19 | $231 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dompe US, Inc.Oxervate | $400 | $793,72724 claims |
| AbbVieRestasis, Alphagan P | $738 | $36,95644 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $466 | $19,54837 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 714 optometrist providers in Oklahoma.
Other optometrist in Edmond
- Selina McGeeEdmond$1.1M
- Tyler GlazeEdmond$9K
- Bibin CherianEdmond$7K
- Sahab AstaniEdmond$5K
- Ryan MeltonEdmond$5K
- Matthew MorrisEdmond$5K
- Tracy MorrisEdmond$5K
- Nathan LighthizerTahlequah$1M
- Lindsey BullTulsa$218K
- Jeff MillerTahlequah$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.